>PROKKA_00001 putative protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain
MKSKLLKTIALTLISVNTIVYPIYAAEVPKFSNLNDVEENIYTHLINRDSNINFIYTGST
REFKDNIVKTIKAAYSKDDYTERSWLEIKPNVNISDGKINTSINFEYLTNKEQEEFIDIE
IKKITDKLINDKMSDFEKVKAINDYLANRYEYDYTLSSSNVYSALITNYTVCQGYSLTAY
KMLKNAGIESRIGVGTNKGASHSWNIVKIEDSWYHLDITNNDSTRSNKYFLVSDKFLEDN
NYKWNRTEYPEALNNK*
>PROKKA_00002 hypothetical protein
MFSKAFGFIFKAIISFVVLIVSIKFLWVSILIFIDRVVNIFNIIG*
>PROKKA_00003 hypothetical protein
MGNKKANLNGSLYWNVVPVSFRKEDTFMTLPGHSQILHNLYKEHDNGYVAIFRKGFKGIY
QRHYKKQDLEEALDVFFSGGYNNELYISMNTFLKPNRTSENLRYLNALYIDIDCYKLNIR
KESVLFFLENDFYNKIIPEPSVVVDSGRGLYLVWFIEPVPSRALTLWRAMQYYLYSALKE
FGADRAALDESRVLRVVGSYNSKSDSYVKIVDFNNFRYTLKDLKSEYLPEIKKEDKKIKK
KRKSNKIHIFNFYGLHKSRMEDIYKLVQLRSYDMKGKRELILFLYRYYATLVEGETVAEE
MTLELNESFIEPLPLNEINSTKSNYIGKYNYKNKTLVELLEISLEEMKHMTSLISKEHKF
QRNNERRKSLRRNENGLTKREQLKKDNLIKIIKLMDEGRKTKEIAETLDISLRMVQKYKK
ELKENNKLYEDLKKEILSINDNYNEDEIQCYDIDLNLEEIEEIFNDDLKKVGS*
>PROKKA_00004 hypothetical protein
MKKTKIEIRLTEVQKEDIKLRAKNKSLKMSEYILNKIYENPESTNDIKDLLRFNIKELLR
LKVEYLNQKKECDDANKNKKIENKLVDLDKIITTLTAMLNDEEFNF*
>PROKKA_00005 Putative DNA-invertase from lambdoid prophage Rac
MIYGYVRVNTKEQLNNNSIEKQIFEIFDVYSNAIIYEETFNNKFTVRPKFLELLDLLNKH
DILVVTELDKFCTSIKEGLKYIKMLINNGVKVHILNMGMIENTSIGNLIIKNLIAFDKFE
EMILKQYSKNKDGRPKKFTLIQLRYALSLLKVNGGKNSYNEVARITGISKSTLIREMKKM
S*
>PROKKA_00006 Transposon Tn3 resolvase
MIFGYMRISTNKEKQKTDRQEITLINYSKENNFTFGDIIPEKISGSVKANYRPKYKSLKE
KLRSNDILIITDVDRLGRDADDIIMEFKNLKASGIRIIPLDVPYLNQWKNVKDDSMYNMI
SDIYITIKAHQAQQEREKIVARINQGLDAARAKGTKLGRPSVKIDPNFIREYTKFKNGIY
GDITATNFAKMLGIGRSTLYKYIKILKNQE*
>PROKKA_00007 Botulinum neurotoxin type B precursor
MPVTINNFNYNDPIDNDNIIMMEPPFARGTGRYYKAFKITDRIWIIPERYTFGYKPEDFN
KSSGIFNRDVCEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLG
DRRVPLEEFNTNIASVTVNKLISNPGEVEQKKGIFANLIIFGPGPVLNENETIDIGIQNH
FASREGFGGIMQMKFCPEYVSVFNNVQENKGASIFNRRGYFSDPALILMHELIHVLHGLY
GIKVDDLPIVPNEKKFFMQSTDTIQAEELYTFGGQDPSIISPSTDKSIYDKVLQNFRGIV
DRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFNKLYKSLMFGFTEIN
IAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKNMGKEYRGQNKAINKQA
YEEISKEHLAVYKIQMCKSVKVPGICIDVDNENLFFIADKNSFSDDLSKNERVEYNTQNN
YIGNDFPINELILDTDLISKIELPSENTESLTDFNVDVPVYEKQPAIKKVFTDENTIFQY
LYSQTFPLNIRDISLTSSFDDALLVSSKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVDD
FVIEANKSSTMDKIADISLIVPYIGLALNVGDETAKGNFESAFEIAGSSILLEFIPELLI
PVVGVFLLESYIDNKNKIIKTIDNALTKRVEKWIDMYGLIVAQWLSTVNTQFYTIKEGMY
KALNYQAQALEEIIKYKYNIYSEEEKSNININFNDINSKLNDGINQAMDNINDFINECSV
SYLMKKMIPLAVKKLLDFDNTLKKNLLNYIDENKLYLIGSVEDEKSKVDKYLKTIIPFDL
STYTNNEILIKIFNKYNSEILNNIILNLRYRDNNLIDLSGYGAKVEVYDGVKLNDKNQFK
LTSSADSKIRVTQNQNIIFNSMFLDFSVSFWIRIPKYRNDDIQNYIHNEYTIINCMKNNS
GWKISIRGNRIIWTLIDINGKTKSVFFEYNIREDISEYINRWFFVTITNNLDNAKIYING
TLESNMDIKDIGEVIVNGEITFKLDGDVDRTQFIWMKYFSIFNTQLNQSNIKEIYKIQSY
SEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLVKDSSVGEILIRSKYNQNSNYINYRNLY
IGEKFIIRRKSNSQSINDDIVRKEDYIHLDFVNSNEEWRVYAYKNFKEQEQKLFLSIIYD
SNEFYKTIQIKEYDEQPTYSCQLLFKKDEESTDDIGLIGIHRFYESGVLRKKYKDYFCIS
KWYLKEVKRKPYKSNLGCNWQFIPKDEGWTE*
>PROKKA_00008 Botulinum neurotoxin type A precursor
MYVEINLGEWLNMNINDNLSINSPVDNKNVVVVRARKTDTIFKAFKVAPNIWVAPERYYG
ESLSIDEEYKVDGGIYDSNFLSQDSEKDKFLQAIITLLKRINSTNAGEKLLSLISTAIPF
PYGYIGGGYYAPNMITFGSAPKSNKKLNSLISSTIPFPYAGYRETNYLSSEDNKNFYASN
IVIFGPGSNIVENNTVFYKKEDAENGMGTMTEIWFQPFLTYKYDQFYIDPAIELMKCLIK
SLYFLYGIKPSDDLVVPYRLRNELENIEYSQLNIVDLLVSGGIDPKFINTDPYWFIDNYF
SNAKKVFEDHRNIYKTEVEGNNAIGNDIKLRLKQKFRINTNDIWELNLNYFSKEFSIMMP
DRFNNALKHFYRKQYYKIDYPENYSINGFVNGQINAQLFLSDRNQDIINKPEEIINLLNG
NNVSLMRSNIYGDGLKSTVDDFYSNYKIPYNRAYEYHFNNSNDSSLDNVNTGVIDNIPEI
IDVNPYKENCDKFSPVQKITSTREINTNIPWPINYLQAQNTNNERFSLSSDFVEVVSSKD
KSLVYSFLSNVMFYLDSIKDNSPIDTDKEYYLWLREIFRNYSFDITATQEINTNCGINKV
VAWFGKALNILNTSDSFVEEFQNLGPSSLINKKENLSMPIIEIDEIPNYMLGLPLNDLNE
KLFNIYLKNILYFKKVYFNFLDQWWTEYYSQYFDLICMAKQSILAQEKLIKQIIQNKLQD
LSKADISMDKLNLMNLATGKTFIDLSNESQIAIDNINDFLNKSAICFFDTNIYPKFISFM
EQCINSVNSNVTTFIQKCTNITEDEKLQLIKLNTFMNIDFEFFDIQNIKDLITSETDLIK
EEKESDYNLFLLTLQEDNNKVIEDISGKNTLVKYSDSISLVYGVNGDALYLKEPNESVSF
SNKVFENGLTNSFSICFWLRNLGEDIITSKLIENKADNCGWEIYFENNGLVFSIVDCNGN
EENIYLSDVISKNWYYISISIDRLRNQLLIFINDKLIANQSIEQILNIYSSSTISLVNEN
NPIYVEGLSILNRSITSEEVVNNYFSYLNNSYIRDISGERLEYNKIYELYNYVFPENSLY
EVTENNNIYLSIKDTNDLNIQGAKFKLINIDTNKQYVQKWDEGVVCLLGDEEKYVDISSE
NNRIQLVSSRDTAKKIIFNNDIFKPNCLTFAYNNKYLSLSFRDRNYNWMIYNNNDNIPKA
AHLWTLKGI*
>PROKKA_00009 transcriptional regulator BotR, P-21
MNKLFLQIKRLKNDNREFQEIFKNFEKTIDIFTRKYNIYDNYNDILYHLWYTLKKVDLSN
FNTQNDLERYISRTLKRYCLDICNKRKIDKKIIYNSEIVGEKLRLIANSYSSYSEVEFND
LISILPDDQKKIIYMKFVEDIKEIDIAKKLNISRQSVYKNKIMALGRLKPILVYIFKKF*
>PROKKA_00010 hypothetical protein
MEHYSVIQNSLNDEIVTISCKADTNLFFYQTVGNVSLFQQTRNYLERWRLIYDANKAAYK
IKSMDSHNTNLVLTWNAPTHNISAQQDSNADNQYWLLLKDIGSNSFIIASYKNPNLVLYA
DTVARNLKLSTLNNSSYIKFIIEDYMISDFNNFTCKISPILDSSKVVQQVAMTDLSVNLY
TWDYGRNQKWTIKYNKEKSAYQFFNTILSNGVLTWISSNGNTVRVSSIAQNNDAQYWLIN
PVSNAYETYTITNLHDTTKALDLYNSQTANGTTIQVFNYHGDDNQKWFIRNP*
>PROKKA_00011 HA 17 kDa subunit
MSVERTFLPDGNYNIKSIFSGSLYLNPVSGSLTFSSESSANNQKWNVEYMAKNRCFKISN
VAEPNKYLSYDNFGFISLDSLSNKCYWFPIKIAVNTYIMLNLNKVNELDYAWDIYDTNEN
ILSQPLLLLPNFDIYNSNQMLKLEKI*
>PROKKA_00012 Hemagglutinin components HA-22/23/53 precursor
MNSSIKKIYNHIQEKVINYSDTIDLADGNYVVSRGDGWILSRQNQILGGSVISNGSTGIV
GDLRVNDNAIPYYYPTPSFNEEYIKNNIQTVFTNFTEANQIPIGFEFSKTAPSNKNLYMY
LQYTYIRYEIIKVLQHEIIERAVLYVPSLGYVKSIEFNLGEKINKDFYFLTNDKCILNEQ
FLYKKILETTKNIPTNNIFNSKVSSTQRVLPYSNGLYVINKGDGYIRTNDKDLIGTLLIE
AGSSGSIIQPRLRNTTRPLFTTSNNTKFSQQYTEERLKDAFNVQLFNTSTSLFKFVEEAP
SNKNICIKAYNTYEKYELIDYQNGSIINTAEYYLPSLGYCEVTNAPSPESEVVKTQVAED
GFVQNGPEEEIVVGVIDPSENIQEINTAISDNYTYSIPDIVDNNPFYILFTVNTTGIYKI
NAQNNLPPLKIYEAIGSGNRNLQSGNLCDDHIKAINYITGFDSSNAKSYLVVLLNKNKNY
YIRVPQTSSNIENQIKFKREEGNIRILANSSVNIIDNLNSTGEHYYTRQSPDVGNYISYE
FTVPGNFNNKDTSNIRLYTSNNQGIGTLFRVTETIDGYDLIDIQHNLHLLNSTKSIRLLN
GAIYILKVEVTELNNYNIRLHIDITN*
>PROKKA_00013 hypothetical protein
MKFDSSASDNIRAIWAFTFALMQASFYDNGNHPKMLIENFKL*
>PROKKA_00014 hypothetical protein
MLKENDRLGLLTLIRKENHKWRTYWYYKCDCGNEKWIRADALNRTKKPTGSCGCLAENTQ
FKKEDITNERFGKLQAIRPTEQKRGNSTVY*
>PROKKA_00015 hypothetical protein
MKGKVTFNISGSGSKSARLTIPAALIELMKITEDNREVEITYEDGKLVVEKVSEYVEGK*
>PROKKA_00016 hypothetical protein
MNAKGHEVDYDEEEVEILDAEGCENECEVLIHKDTQKFIITFVSTDEDFEEMRYYEVELG
VAK*
>PROKKA_00017 hypothetical protein
MNKIIRVKVSKEIRNIIDLLSREKNKSKSQMLREILKIYKENNTTRNKNEVEDYSIIIHI
PEKEGFTKEKYQKYADKITNDDIMIIINDLYNIQA*
>PROKKA_00018 hypothetical protein
MYNLINSLSNGDQKMFWLIFDLIVIATFHLIWFSYLFFKRKDSELQSIRKPLYYRSLQYI
LCICLGLLIAA*
>PROKKA_00019 hypothetical protein
MLIIIVIILYIGISLYSKHLLYIQSYARFKRELLYNREQNVKRVCNKSVKKIEWICFVPG
INLITVLALSIMILIDKY*
>PROKKA_00020 hypothetical protein
MKMIYANFLILILIIPISFYLVICKYNGIKFFNMFSVNTMEKFLNENNKLAIATILMMAL
STALTFLIFSFMGLSNIKNLR*
>PROKKA_00021 hypothetical protein
MSIILISELMTKLNSNSFNREQLNIIEKYNNKDKKLFLTTICIVFASSIFDSIFRINLIF
DIIDIVIIILSMLILIRYLYFKITMKKSLLIELQEIENKKMKIV*
>PROKKA_00022 hypothetical protein
MKILIDEKQYLEIMELLNMINREKATLLASFNLYLNDNERCLYENVKRENKKYLSLMKQL
DKNKKNNIRKRLIAAVEKWIECEVTGDEAMTQIIELLEIKLTN*
>PROKKA_00023 hypothetical protein
MNMPTIQELTQIGEVIIIWIKYMLMHLAVAMPIMFIVMKFLNVNKKFAKLLK*
>PROKKA_00024 hypothetical protein
MQMEEIKKLLTINKNWKEKFKGDLLDNLLEKCVDIEKYIDLITNEWMNIWISVTKDKEIR
KIYYDFNKQIKELDIRRLKVEYEVIYNIYKYSKELEDSNNESTNNIENIIKWINIIDVNS
LEELENALDEQIRYSL*
>PROKKA_00025 Helix-destabilizing protein
MNKVVLIGRLTKDPEVKFTQENGKAVTKITLAVDKYNSKSGQKEADFVPIVVWDKQAESI
GNYMKKGSQIAISGRIQTRNYEEKDGTKRYVTEVIASEVQFLSRVNNVNSEDNESK*
>PROKKA_00026 hypothetical protein
MLKSKKEYENIKKSNASKKLVQVALEDFKMSTLKYENSKKIRDSIKNIN*
